US FDA gathering information on MDH and Everest spice products amidst carcinogenic pesticide concerns

US Food and Drug Administration (FDA) is currently investigating products from spice manufacturers MDH and Everest following Hong Kong's decision to halt sales of certain items due to the alleged presence of high levels of a carcinogenic pesticide. Earlier this month, Hong Kong suspended the sale of three MDH spice blends and an Everest spice mix for fish curries.